DHTKD1 and central nervous system cancer: Survivin overexpresses in several human tumors including gliomas [36] and prostate cancer [37]; thus surviving promoter is a good candidate for tumor-specific regulated E1a expression in gliomas [38, 39] and both PSA-producing and -nonproducing prostate cancers.